Hematopoietic reprogramming reflects the selective and evolutionarily conserved engagement of transcription factor networks that encode innate immune memory in long-lived stem cells.

The preclinical drug from Vanqua Bio is designed to inhibit “C5aR1,” a part of the immune system that regulates inflammation.

Two therapies can be better than one for treating some cancers, concludes a Yale study published Oct. 22 in JCI Insight that ...

Inflammation is a critical component of the immune response that plays a pivotal role in maintaining tissue homeostasis.

Lifelong viral infections can quietly alter the immune system, with effects that persist over the time. Viruses such as the ...

COVID-19 vaccines were game changing during the course of the pandemic; now another benefit is emerging—the same vaccines are ...

Researchers found that COVID-19 mRNA vaccines, when given within 100 days of starting immune checkpoint inhibitors, were ...

The oral C5aR1 antagonist is designed to modulate neutrophil-driven inflammation, a central mechanism underlying many inflammatory ...

NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction . NMRA-215 demonstrated best-in-class weight loss of up to 26% in com ...

Scientists from the University of California have warned that some ingredient combinations may not be as healthy as they seem ...

Inmune Bio ( ($INMB) ) has shared an announcement. On October 23, 2025, INmune Bio Inc. announced it will host a conference call on October 30, ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...